Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Cavanaugh: Diabetes Management Issues for Patients With Chronic Kidney Disease. (0.11 sec) 

Diabetes Management Issues for Patients With Chronic Kidney Disease


KL Cavanaugh - Clinical Diabetes, 2007 - Am Diabetes Assoc
Chronic kidney disease (CKD) is a common condition that is estimated to affect
11% of the US population, or 19 million people, and > 50 million people
worldwide. 1,2 Similarly, diabetes is of an epidemic scale, with prevalence ...
Related articles - BL Direct - All 2 versions

Reproducibility of renal function measurements in adult men with diabetic nephropathy: …


R Agarwal - Am J Nephrol, 2007 - content.karger.com
Background/Aim: Measurement of the renal function is critical to follow
progression of kidney disease. Short-term and long-term variabilities in these
measurements have significant impacts on clinical decision making and ...
Cited by 7 - Related articles - BL Direct - All 5 versions

Interpreting glycosylated hemoglobin in diabetic patients on peritoneal dialysis


AH Tzamaloukas - ADVANCES IN PERITONEAL DIALYSIS, 1996 - advancesinpd.com
The limitations and usefulness of glycosylated hemoglobin (HbA) as a means of
assessing glycemic control in peritoneal dialysis (PD) and the importance of
good glycemic control in diabetics on PD were analyzed. HbA J levels may be ...
Cited by 10 - Related articles - Cached - BL Direct - All 2 versions

Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal …


L Morgan, CB Marenah, WJ Jeffcoate, AG … - Diabetic medicine, 1996 - interscience.wiley.com
This study investigates the reliability of glycated haemoglobin, measured by
electroendosmosis or by affinity chromatography, fructosamine, and albumin
adjusted fructosamine, as indices of glycaemic control in Type 1 diabetes ...
Cited by 12 - Related articles - BL Direct - All 3 versions

The metabolic effects of troglitazone in patients with diabetes and end-stage renal disease


P Mohideen, M Bornemann, J Sugihara, V … - Endocrine, 2005 - Springer
Received July 22, 2005; Revised August 30, 2005; Accepted September 6, 2005.
Author to whom all correspondence and reprint requests should be addressed:
Richard Arakaki, MD, Department of Medicine, 1356 Lusitana Street, 7th ...
Cited by 4 - Related articles - BL Direct - All 3 versions

Update on erythropoietin treatment: should hemoglobin be normalized in patients with …

- asnjournals.org
E Paoletti, G Cannella - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol
The partial correction of ESRD anemia by recombinant human erythropoietin (EPO)
has resulted both in generalized improvement in quality of life and physical
activity and in reduced mortality and hospitalization rate. The question ...
Cited by 15 - Related articles - BL Direct - All 5 versions

Assessing glycemic control in patients with diabetes and end-stage renal failure


A Ansari, S Thomas, D Goldsmith - American Journal of Kidney Diseases, 2003 - Elsevier
Blood glucose monitoring is important in optimizing long-term outcomes in
diabetic patients. Reliance on near-patient testing and the use of longer term
measures of glycation are the current cornerstones. However, as this review ...
Cited by 23 - Related articles - BL Direct - All 11 versions

Severe hypoglycemia in type I diabetic patients with impaired kidney function.


I Mühlhauser, G Toth, PT Sawicki, M Berger - Diabetes care, 1991 - Am Diabetes Assoc
OBJECTIVE: To assess the frequency and possible risk indicators of severe
hypoglycemia in insulin-dependent (type I) diabetic patients with impaired
kidney function. RESEARCH DESIGN AND METHODS: Retrospective follow-up ...
Cited by 20 - Related articles - All 5 versions

Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of …

- diabetesjournals.org
K Rave, T Heise, A Pfützner, L Heinemann, … - Diabetes Care, 2001 - Am Diabetes Assoc
RESULTS—Peak plasma free insulin levels with insulin lispro (359 [NP] vs. 254
pmol/l [DC]) were higher and time to maximal insulin concentrations (85 [NP] vs.
99 min [DC]) shorter than with regular insulin (213 [NP] vs. 144 pmol/l ...
Cited by 24 - Related articles - BL Direct - All 10 versions

Protektion der Nierenfunktion bei Diabetikern


C Hasslacher - Der Internist, 2007 - Springer
DiediabetischeNephropathieistheu- teindenIndustrienationendiehäu-
figsteUrsachefüreineNierenersatz- therapiemitnachwievorsehrun-
günstigerPrognose.Sobeträgtdas5- Jahres-Überlebeneinesdialysepflich- ...
Related articles - BL Direct


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google